期刊文献+

己酮可可碱对非酒精性脂肪性肝炎大鼠肝脏基因表达谱的影响 被引量:1

Effects of Pentoxifylline on Hepatic Gene Expression Profiling in Nonalcoholic Steatohepatitis Rats
在线阅读 下载PDF
导出
摘要 背景:己酮可可碱(PTX)可减轻高脂饮食大鼠脂肪性肝炎和肝纤维化的程度,但其作用机制尚未明确。目的:探讨PTX对非酒精性脂肪性肝炎(NASH)大鼠肝脏基因表达谱的影响。方法:24只Sprague-Dawley大鼠在高脂饮食4周后随机分为模型组(n=12)和PTX干预组(n=12,PTX每天100mg/kg),并继续予高脂饮食;6只普通饮食饲养大鼠作为对照组。于实验第24周处死大鼠,应用含15650条基因的大鼠U230A芯片检测肝脏基因表达的改变。结果:与模型组相比,PTX干预组共出现370条差异表达基因,其中模型组较对照组上调而PTX干预后下调的基因57条,主要包括炎症/免疫反应相关基因、细胞信号转导相关基因、细胞外基质和细胞黏附分子基因、代谢酶和生物转化相关基因、离子通道/运输蛋白基因等;模型组较对照组下调而PTX干预后上调的基因25条,其功能涉及细胞信号转导、脂质代谢、生物转化等。结论:PTX可能通过影响NASH大鼠肝脏多种结构和功能基因的表达而有助于NASH和肝纤维化的防治。 Background: It has been proven that pentoxifylline (PTX) can improve steatohepatitis and fibrosis in rats fed with high fat diet. but its mechanism remains uncertain. Aims: To investigate the effects of PTX on hepatic gene expression profiling in a rat model of nonalcoholic steatohepatitis (NASH). Methods: Thirty Sprague-Dawley rats were enrolled, among them, 24 fed with high fat diet for 4 weeks were randomly allocated into two groups, model group (n=12) and PTX- intervention group (n=12). High fat diet was given continuously in both groups, and in the intervention group, PTX-contained drinking water (100 mg/kg per day) was supplied. Meanwhile, 6 rats fed with standard diet served as control group. All rats were sacrificed at the 24th week and the hepatic gene expressions were detected by oligonucleotide microarray analysis with Affymetrix GeneChip Rat U230A consisting of 15 650 genes. Results: The expression of 370 genes in the PTX-intervention group changed over twofold as compared with those in the model group, among which, 57 were up-regulated in the model group (r,s. control group), but down-regulated after PTX-intervention (vs. model group), including related genes of inflammatory/immune response, cellular signal transduction, extracellular matrix and cell adhesion molecules, metabolic enzyme and biotransformation, ion channels/transporters, etc; 25 were down-regulated in the model group, but up-regulated after PTX-intervention, the functions involved were cellular signal transduction, lipid metabolism, and biotransformation, etc. Conclusions: PTX can affect the expression of many structural and functional genes in the liver of NASH rats, and may be useful in the prevention and treatment of NASH and liver fibrosis.
出处 《胃肠病学》 2005年第5期263-268,共6页 Chinese Journal of Gastroenterology
基金 上海市青年科技启明星计划和跟踪计划(No.03QMH1409)资助
作者简介 范建高,Email:fanjg@citiz.net
  • 相关文献

参考文献13

  • 1Satapathy SK, Garg S, Chauhan R, Sakhuja P, Malhotra V, Sharma BC, Sarin SK. Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis. Am J Gastroenterol, 2004, 99: 1946~1952.
  • 2Akriviadis E, Botla R, Briggs W, Han S, Reynolds T,Shakil O. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebocontrolled trial. Gastroenterology, 2000, 119: 1637~1648.
  • 3钱燕,范建高,郑晓英,李锋,陆元善.己酮可可碱对高脂饮食大鼠脂肪性肝炎并肝纤维化的干预作用[J].肝脏,2005,10(2):136-137. 被引量:9
  • 4王泰龄,刘霞,周元平,何静雯,张晶,李宁章,段钟平,王宝恩.慢性肝炎炎症活动度及纤维化程度计分方案[J].中华肝脏病杂志,1998,6(4):195-197. 被引量:388
  • 5中华肝脏病学会肝纤维化学组.肝纤维化诊断及疗效评估共识[J].中华肝脏病杂志,2002,10(5):327-328. 被引量:615
  • 6范建高,徐正婕,王国良,丁晓东,田丽艳,郑晓英.大鼠非酒精性脂肪性肝炎形成过程中血清内毒素含量的变化[J].中华肝脏病杂志,2003,11(2):73-76. 被引量:43
  • 7Preaux AM, Mallat A, Rosenbaum J, Zafrani ES, Mavier P. Pentoxifylline inhibits growth and collagen synthesis of cultured human hepatic myofibroblast-like cells. Hepatology, 1997, 26: 315~322.
  • 8Raetsch C, Jia JD, Boigk G, Bauer M, Hahn EG,Riecken EO, Schuppan D. Pentoxifylline downregulates profibrogenic cytokines and procollagen I expression in rat secondary biliary fibrosis. Gut, 2002, 50: 241~247.
  • 9Inagaki Y, Mamura M, Kanamaru Y, Greenwel P, Nemoto T, Takehara K, Ten Dijke P, Nakao A. Constitutive phosphorylation and nuclear localization of Smad3 are correlated with increased collagen gene transcription in activated hepatic stellate cells. J Cell Physiol, 2001, 187:117~123.
  • 10Deaciuc Ⅳ, Doherty DE, Burikhanov R, Lee EY,Stromberg AJ, Peng X, de Villiers WJ. Large-scale gene profiling of the liver in a mouse model of chronic, intragastric ethanol infusion. J Hepatol, 2004, 40: 219~227.

二级参考文献14

  • 1范建高,丁晓东,王国良,徐正婕,田丽艳,郑晓英.高脂饮食性非酒精性脂肪性肝病大鼠肝脏PPAR-γ表达增强[J].肝脏,2004,9(4):225-228. 被引量:21
  • 2王泰龄,刘霞,高琳,赵静波,王宝恩.对慢性肝炎分类、分级分期的探讨[J].肝脏病杂志,1995,3(3):130-133. 被引量:22
  • 3Horton JD, Shah NA, Warrington JA, et al. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc Natl Acad Sci U S A,2003, 100: 12027-12032.
  • 4Yu S, Matsusue K, Kashireddy P, et al. Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gammal (PPAR gamma1)overexpression. J Biol Chem, 2003, 278: 498-505.
  • 5Lee Y, Wang MY, Kakuma T, et al. Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia. J Biol Chem,2001,276:5629-5635,.
  • 6Sorenson CM. Bcl-2 family members and disease. Biochim Biophys Acta, 2004, 1644: 169-177.
  • 7Raetsch C, Jia JD, Boigk G, et al. Pentoxifylline down regulates profibrogenic cytokines and procollagen I expression in rat secondary biliary fibrosis. Gut,2002,50: 241-247.
  • 8Akriviadis E, Botla R, Briggs W, et al. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebocontrolled trial. Gastroenterology, 2000,119:1637-1648.
  • 9Sanjay K, Grag S, Sakhuja P, et al. Pentoxyfylline as a novel therapy for nonalcoholic steatohepatitis: a pilot study. Gastroenterology, 2003, 124:A758.
  • 10Vial P, Riquelme A, Pizarro M, et al. Pentoxifyline does not prevent early profibrogenic events in a rat model of nonalcoholic steatohepatitis.Gastroenterology, 2003, 124: A757.

共引文献1060

同被引文献29

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部